Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier

doi:10.3748/wjg.v9.i6.1191

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2842)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

437

HTML

2195

Figures (1-5)

112

Tables (1-2)

Sum=2842

Jun 15, 2003 (publication date) through May 3, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 15, 2003; 9(6): 1191-1195
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1191

Full Size Figure Download Figure

Figure 4 PCR identification of the pcDNA3. 1 (+)-MG7/PADRE plasmid harbored by the Salmonella typhimurium SL3261: By PCR, a fragment of 800bp was amplified (d), suggesting the existence of epitope genes and removal of carrier fragment.

Citation: Guo CC, Ding J, Pan BR, Yu ZC, Han QL, Meng FP, Liu N, Fan DM. Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier. World J Gastroenterol 2003; 9(6): 1191-1195
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1191.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1191